[Epidemiology, risk factors and in vitro susceptibility in candidaemia due to non-Candida albicans species]

Rev Iberoam Micol. 2016 Oct-Dec;33(4):248-252. doi: 10.1016/j.riam.2016.04.003. Epub 2016 Oct 13.
[Article in Spanish]

Abstract

Background: Invasive fungal infection (IFI) has increased in recent years due to there being a greater number of risk factors. IFI caused by Candida is the most frequent, and although Candida albicans is the most isolated species, there is currently a decrease of C. albicans and an increase of other species of the genus.

Aims: To analyse the epidemiology, risk factors, and antifungal susceptibility of blood culture isolates of non-C.albicans Candida species in our hospital in the last 12years.

Methods: A retrospective study was conducted on 107 patients with candidaemia admitted to our hospital. Candida isolates susceptibility to fluconazole, itraconazole, voriconazole, amphotericinB, 5-fluorocytosine, caspofungin, micafungin, and anidulafungin was determined by means of a microdilution technique (Sensititre Yeast One; Izasa, Spain).

Results: From a total of 109 strains, 59 belonged to non-C. albicans Candida species: 25 Candida parapsilosis complex, 14 Candida glabrata complex, 13 Candida tropicalis, 4 Candida krusei, 1 Candida lipolytica, 1 Candida membranaefaciens, and 1 Candida pulcherrima. The most common risk factor in adults and children was catheter use. It was observed that 8.5% of those non-C.albicans strains were resistant to fluconazole.

Conclusions: The results of this work confirm that it is necessary to know the epidemiology of non-C.albicans Candida species, the in vitro susceptibility of the species involved, and the main risk factors, especially in patients with predisposing conditions.

Keywords: Candida; Candidaemia; Candidemia; Epidemiology; Epidemiología; Factores de riesgo; Risk factors; Sensibilidad; Susceptibility.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antifungal Agents / pharmacology*
  • Antifungal Agents / therapeutic use
  • Candida / drug effects*
  • Candida / isolation & purification
  • Candidemia / drug therapy
  • Candidemia / epidemiology*
  • Candidemia / microbiology
  • Female
  • Humans
  • Male
  • Microbial Sensitivity Tests
  • Middle Aged
  • Mycology / methods
  • Retrospective Studies
  • Risk Factors

Substances

  • Antifungal Agents